Viral Hepatitis Mapping Project: National Reports
Details
Overview
The Viral Hepatitis Mapping Project aims to improve understanding of chronic hepatitis B (CHB) and C (CHC) in Australia by examining regional variations in prevalence and care uptake.
It supports Australia’s healthcare reform, with a focus on enhancing access to treatment and care, as outlined in the National Hepatitis B and C Strategies (2018-22). Future reports will track progress towards new targets in the upcoming 2025 strategies.
By identifying areas with high prevalence or low treatment uptake, the project helps prioritise interventions and improve service delivery where it’s most needed.
The project’s National Report and Online Portal are updated annually to track changes in CHB and CHC epidemiology and assess the impact of public health efforts on diagnosis and treatment access.
For more on the National Hepatitis B Strategy, including mortality targets and projections for prevalence and care uptake, refer to the National Surveillance for Hepatitis B Indicators Report.
Latest National Reports
Viral Hepatitis Mapping Project: National Report, Hepatitis B 2023 (published 2025)
This report contains estimates of chronic hepatitis B prevalence, treatment and management at a state and territory, Primary Health Network (PHN), remoteness area, and Statistical Area 3 level. This report also includes data regarding the cultural and linguistic diversity of those affected by chronic hepatitis B, including by region. Key indicators included in this report can be further explored using the Online Portal, which provides interactive visualisations of these variations.
Download the Viral Hepatitis Mapping Project: National Report, Hepatitis B 2023
What’s new in this report?
- Further assessment of trends in diagnosis, care and treatment during 2018–2023
- First-ever estimates for Australia of the hepatitis B cascade of care according to priority population (people born overseas and Aboriginal and Torres Strait Islander peoples).
- Expanded assessment of monitoring over time, providing increased understanding of long-term trends in care uptake during the total period of available data (2014–2023)
- Serology testing data (including hepatitis B and C) through mid-2024.
- Updated liver cancer data according to PHN to 2019.
Key points:
- There were substantial gaps nationally in hepatitis B treatment uptake (12.6%) and care uptake (24.5%) in 2023
- Only one PHN has met the current treatment uptake target, and no other PHN is even on track to meet the target until after 2030
- Almost half (44.7%) of people with CHB had no evidence of care at any time during 2014–2023
- Hepatitis serology testing (required for diagnosis) declined in 2020 and has not yet returned to baseline levels
- There is evidence of substantial disparities in treatment and care uptake according to priority population
Viral Hepatitis Mapping Project: National Report, Hepatitis C 2023-2024 (published 2025)
This report presents the most recent available treatment data on hepatitis C through June 2024 and the assessment of ongoing trends from 2016. The data enable readers to identify hepatitis C treatment uptake variation in local areas and to assess progress in delivering care to those affected.
Download the Viral Hepatitis Mapping Project: National Report, Hepatitis C 2023-2024
What’s new in this report?
- Further assessment of trends in treatment uptake during March 2016 – June 2024
Key points:
- Between March 2016 – June 2024, a total of 108,459 people received hepatitis C treatment
- There were annual declines in the number of people treated each year from 2016 to 2022 of between 20-45%, but between 2022 and 2024 there was only a 3.2% decline nationally
- Estimated treatment uptake varied widely by PHN and continued to be generally lower in remote and very remote regions, and regions of higher estimated hepatitis C prevalence
- In a number of PHNs, most commonly in NSW, the monthly average number of people treated each year increased between 2022 and 2024
Viral Hepatitis Mapping Project: Online Portal
The Mapping Project’s Online Portal is an interactive tool which allows stakeholders to explore the data presented in the latest National Report on a deeper level, and directly compare regions of interest.
More information
The Project is a joint initiative of the WHO Collaborating Centre for Viral Hepatitis Epidemiology, The Doherty Institute and ASHM, funded by the Australian Government Department of Health.
For general enquiries about the Viral Hepatitis Mapping Project, contact Adi Mondel at [email protected] or 0411 539 674. To discuss specific data, for previous reports, or to request additional information for your area, contact Jennifer MacLachlan at [email protected]. Requests for specific and further data to assist with planning and sector development are welcomed.
Conferences and Events
Discover our events calendar, featuring impactful health conferences and educational gatherings. Join health professionals, researchers, and community organisations in HIV, BBV, sexual health and other health fields. Explore our calendar to find engaging opportunities tailored to your interests and professional development.
